SCTHERAPY23 LTD

Company Registration Number:
15188264 (England and Wales)

Unaudited statutory accounts for the year ended 31 October 2024

Period of accounts

Start date: 04 October 2023

End date: 31 October 2024

SCTHERAPY23 LTD

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 10

SCTHERAPY23 LTD

Company Information

for the Period Ended 31 October 2024




Director: Asen Trifonov
Registered office: 38
Torrington Gardens
Loughton
England
IG10 3TB
Company Registration Number: 15188264 (England and Wales)

SCTHERAPY23 LTD

Balance sheet

As at 31 October 2024


Notes
13 months to
31 Oct 2024
£
Fixed assets
Total fixed assets: -
Current assets
Debtors: 5 1,191
Cash at bank and in hand: 1,508
Total current assets: 2,699
Creditors: amounts falling due within one year: 6 ( 2,575 )
Net current assets (liabilities): 124
Total assets less current liabilities: 124
Total net assets (liabilities): 124

The notes form part of these financial statements

SCTHERAPY23 LTD

Balance sheet continued

As at 31 October 2024


Notes
13 months to
31 Oct 2024
£
Capital and reserves
Called up share capital: 1
Profit and loss account: 123
Shareholders funds: 124

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 15 April 2025
And Signed On Behalf Of The Board By:

Name: Asen Trifonov
Status: Director

The notes form part of these financial statements

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Employees

    13 months to
    31 Oct 2024
    Average number of employees during the period 1

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 3. Off balance sheet disclosure

    No

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

4. Dividends

13 months to
31 Oct 2024
£
Dividends paid 10,000

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

5. Debtors

13 months to
31 Oct 2024
£
Trade debtors 1,191
Total 1,191

SCTHERAPY23 LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

6.Creditors: amounts falling due within one year note

13 months to
31 Oct 2024
£
Trade creditors 200
Taxation and social security 2,375
Total 2,575